| Dr Dennis John Firchau, MD | |
|
200 Hawkins Dr, Iowa City, IA 52242-1007 | |
| (319) 356-4433 | |
| (319) 384-8053 |
| Full Name | Dr Dennis John Firchau |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 20 Years |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437236429 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State University Of Iowa | 7618884230 | 1476 |
News Archive
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
Successful aging means more than good health. It means taking charge of your personal wellbeing so that you can continue to live a vibrant, independent life, regardless of your age, according to Dr. Terri Ginsberg of the New Jersey Institute for Successful Aging at the UMDNJ-School of Osteopathic Medicine.
NUST MISIS material scientists have presented antibacterial nano-coatings based on boron nitride, which are highly effective against microbial pathogens (up to 99.99%).
New research uncovers what may be a primary neuron-damaging insult that occurs in an inherited form of a devastating neurodegenerative disorder. The study, published by Cell Press in the August 26th issue of the journal Neuron, describes a critical mechanistic link between a mutant protein and disease pathogenesis in an animal model of amyotrophic lateral sclerosis (ALS).
UK-based researchers have developed a blood test that can predict whether patients with breast cancer will experience a relapse after receiving treatment, months before tumors are visible using hospital scans.
› Verified 1 days ago
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
Successful aging means more than good health. It means taking charge of your personal wellbeing so that you can continue to live a vibrant, independent life, regardless of your age, according to Dr. Terri Ginsberg of the New Jersey Institute for Successful Aging at the UMDNJ-School of Osteopathic Medicine.
NUST MISIS material scientists have presented antibacterial nano-coatings based on boron nitride, which are highly effective against microbial pathogens (up to 99.99%).
New research uncovers what may be a primary neuron-damaging insult that occurs in an inherited form of a devastating neurodegenerative disorder. The study, published by Cell Press in the August 26th issue of the journal Neuron, describes a critical mechanistic link between a mutant protein and disease pathogenesis in an animal model of amyotrophic lateral sclerosis (ALS).
UK-based researchers have developed a blood test that can predict whether patients with breast cancer will experience a relapse after receiving treatment, months before tumors are visible using hospital scans.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dennis John Firchau, MD 200 Hawkins Dr, Iowa City, IA 52242-1007 Ph: (319) 356-4433 | Dr Dennis John Firchau, MD 200 Hawkins Dr, Iowa City, IA 52242-1007 Ph: (319) 356-4433 |
News Archive
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
Successful aging means more than good health. It means taking charge of your personal wellbeing so that you can continue to live a vibrant, independent life, regardless of your age, according to Dr. Terri Ginsberg of the New Jersey Institute for Successful Aging at the UMDNJ-School of Osteopathic Medicine.
NUST MISIS material scientists have presented antibacterial nano-coatings based on boron nitride, which are highly effective against microbial pathogens (up to 99.99%).
New research uncovers what may be a primary neuron-damaging insult that occurs in an inherited form of a devastating neurodegenerative disorder. The study, published by Cell Press in the August 26th issue of the journal Neuron, describes a critical mechanistic link between a mutant protein and disease pathogenesis in an animal model of amyotrophic lateral sclerosis (ALS).
UK-based researchers have developed a blood test that can predict whether patients with breast cancer will experience a relapse after receiving treatment, months before tumors are visible using hospital scans.
› Verified 1 days ago
Dr. John Phillip Lee, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Pathology, Iowa City, IA 52242 Phone: 319-384-9605 Fax: 319-467-5193 | |
Dr. Carol Joy Holman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-3981 Fax: 319-384-8051 | |
James A Goeken, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1966 Fax: 319-384-8053 | |
Sergei I Syrbu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-7372 Fax: 319-384-8053 | |
Jo A Benda, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4436 Fax: 319-384-8052 | |
Amani Abdalla Bashir, MBBS Pathology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Drive, University Of Iowa Hospitals And Clinics, Iowa City, IA 52242 Phone: 319-467-5706 Fax: 319-356-8470 | |
Mr. Paul J Belding, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 321 E Market St Ste 102, Iowa City, IA 52245 Phone: 319-337-7284 Fax: 319-337-7284 |